Important role of hypothalamic Y2 receptors in body weight regulation revealed in conditional knockout mice
- 18 June 2002
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 99 (13) , 8938-8943
- https://doi.org/10.1073/pnas.132043299
Abstract
Neuropeptide Y is implicated in energy homeostasis, and contributes to obesity when hypothalamic levels remain chronically elevated. To investigate the specific role of hypothalamic Y2 receptors in this process, we used a conditional Y2 knockout model, using the Cre-lox system and adenoviral delivery of Cre-recombinase. Hypothalamus-specific Y2-deleted mice showed a significant decrease in body weight and a significant increase in food intake that was associated with increased mRNA levels for the orexigenic NPY and AgRP, as well as the anorexic proopiomelanocortin (POMC) and cocaine- and amphetamine-regulated transcript (CART) in the arcuate nucleus. These hypothalamic changes persisted until at least 34 days after Y2 deletion, yet the effect on body weight and food intake subsided within this time. Plasma concentrations of pancreatic polypeptide and corticosterone were 3- to 5-fold increased in hypothalamus-specific Y2 knockout mice. Germ-line Y2 receptor knockout also produced a significant increase in plasma levels of pancreatic polypeptide. However, these mice differed from conditional knockout mice in that they showed a sustained reduction in body weight and adiposity associated with increased NPY and AgRP but decreased POMC and CART mRNA levels in the arcuate nucleus. The transience of the observed effects on food intake and body weight in the hypothalamus-specific Y2 knockout mice, and the difference of this model from germ-line Y2 knockout mice, underline the importance of conditional models of gene deletion, because developmental, secondary, or extrahypothalamic mechanisms may mask such effects in germ-line knockouts.Keywords
This publication has 43 references indexed in Scilit:
- Orexigenic effect of the melanocortin MC4 receptor antagonist HS014 is inhibited only partially by neuropeptide Y Y1 receptor selective antagonistsCanadian Journal of Physiology and Pharmacology, 2000
- Y-receptor subtypes—how many more?Trends in Neurosciences, 1997
- Cloning and Functional Expression of a cDNA Encoding a Human Type 2 Neuropeptide Y ReceptorJournal of Biological Chemistry, 1995
- Acre-transgenic mouse strain for the ubiquitous deletion ofloxP-flanked gene segments including deletion in germ cellsNucleic Acids Research, 1995
- Pancreatic polypeptide enhances plasma glucocorticoid concentration in rats: Possible role in hypoglycemic stressLife Sciences, 1995
- Pancreatic polypeptide infusions reduce food intake in Prader-Willi syndromePeptides, 1993
- Pancreatic Polypeptide Response to Secretin in Obesity: Effects of Glucose IntoleranceHormone and Metabolic Research, 1988
- Dexamethasone treatment increases neuropeptide Y levels in rat hypothalamic neuronesLife Sciences, 1988
- Neuroreptide Y: Stimulation of feeding and drinking by injection into the paraventricular nucleusLife Sciences, 1984
- Pancreatic polypeptide: a unique model for vagal control of endocrine systemsJournal of the Autonomic Nervous System, 1983